Cutaneous tuberculosis (CTB) is the result of a chronic infection by Mycobacterium
tuberculosis, M. ovis and occasionally by the Calmette-Guerin bacillus. The clinical
manifestations are variable and depend on the interaction of several factors
including the site of infection and the host's immunity. This article revises the
current knowledge about this disease's physiopathology and immunology as well as
detailing the possible clinical presentations.
BACKGROUND AND PURPOSE:TA is a branch of image processing that seeks to reduce image information by extracting texture descriptors from the image. TA of MR images of anatomic structures in mild AD and aMCI is not well-studied. Our objective was to attempt to find differences among patients with aMCI and mild AD and normal-aging subjects, by using TA applied to the MR images of the CC and the thalami of these groups of subjects.
The evolution in the knowledge of tuberculosis' physiopathology allowed not only
a better understanding of the immunological factors involved in the disease
process, but also the development of new laboratory tests, as well as the
establishment of a histological classification that reflects the host's ability
to contain the infectious agent. At the same time, the increasing bacilli
resistance led to alterations in the basic tuberculosis treatment scheme in
2009. This article critically examines laboratory and histological
investigations, treatment regimens for tuberculosis and possible adverse
reactions to the most frequently used drugs.
The Portuguese version of the P-QoL questionnaire is a valid and reliable instrument to assess quality of life in Brazilian women with pelvic organ prolapse.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.